ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

Drug-Repositioning Screens Identify Triamterene as a Selective Drug for the Treatment of DNA Mismatch Repair Deficient Cells.

Delphine Guillotin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.